Elsea, David
Fan, Lin
Mihai, Adela
Moustaid, Fadoua El
Simmons, Daniel
Monberg, Matthew
Muston, Dominic
Article History
Accepted: 4 May 2022
First Online: 29 August 2022
Change Date: 15 September 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s41669-022-00372-0
Declarations
:
: Funding for this research was provided by AstraZeneca and Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.
: Lin Fan, Matthew Monberg and Dominic Muston are employees of Merck & Co., Inc. Adela Mihai and Dan Simmons are employees of AstraZeneca. David Elsea and Fadoua El Moustaid are employees of BresMed America, which received funding from Merck & Co, Inc. and AstraZeneca for this work.
: Not applicable.
: Not applicable.
: Not applicable.
: Model inputs are described in the manuscript, electronic supplementary material, and references. No further data and material are available.
: The Excel model is not available. Note, the Excel model was made available to the journal during the peer review process.
: DE performed the analysis and interpretation of the data, drafted the manuscript, approved the final version, and agrees to be accountable for all aspects of the work. LF, AM, DS, MM, and DM reviewed the analysis and interpretation of the data, critically revised the manuscript, approved the final version, and agree to be accountable for all aspects of the work. FEM performed the analysis and interpretation of the data, critically revised the manuscript, approved the final version, and agrees to be accountable for all aspects of the work.